1. Home
  2. LUNG vs MVBF Comparison

LUNG vs MVBF Comparison

Compare LUNG & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • MVBF
  • Stock Information
  • Founded
  • LUNG 1995
  • MVBF 1997
  • Country
  • LUNG United States
  • MVBF United States
  • Employees
  • LUNG N/A
  • MVBF N/A
  • Industry
  • LUNG Industrial Specialties
  • MVBF Major Banks
  • Sector
  • LUNG Health Care
  • MVBF Finance
  • Exchange
  • LUNG Nasdaq
  • MVBF Nasdaq
  • Market Cap
  • LUNG 124.0M
  • MVBF 278.3M
  • IPO Year
  • LUNG 2020
  • MVBF N/A
  • Fundamental
  • Price
  • LUNG $2.87
  • MVBF $23.22
  • Analyst Decision
  • LUNG Buy
  • MVBF Buy
  • Analyst Count
  • LUNG 6
  • MVBF 4
  • Target Price
  • LUNG $11.53
  • MVBF $24.75
  • AVG Volume (30 Days)
  • LUNG 317.8K
  • MVBF 45.9K
  • Earning Date
  • LUNG 07-30-2025
  • MVBF 07-28-2025
  • Dividend Yield
  • LUNG N/A
  • MVBF 2.88%
  • EPS Growth
  • LUNG N/A
  • MVBF N/A
  • EPS
  • LUNG N/A
  • MVBF 1.46
  • Revenue
  • LUNG $87,473,000.00
  • MVBF $146,101,000.00
  • Revenue This Year
  • LUNG $18.02
  • MVBF N/A
  • Revenue Next Year
  • LUNG $18.17
  • MVBF $14.22
  • P/E Ratio
  • LUNG N/A
  • MVBF $16.15
  • Revenue Growth
  • LUNG 19.84
  • MVBF N/A
  • 52 Week Low
  • LUNG $2.50
  • MVBF $15.59
  • 52 Week High
  • LUNG $9.37
  • MVBF $25.24
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.07
  • MVBF 79.48
  • Support Level
  • LUNG $2.62
  • MVBF $22.85
  • Resistance Level
  • LUNG $2.88
  • MVBF $23.63
  • Average True Range (ATR)
  • LUNG 0.17
  • MVBF 0.50
  • MACD
  • LUNG 0.05
  • MVBF 0.13
  • Stochastic Oscillator
  • LUNG 39.68
  • MVBF 95.93

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

Share on Social Networks: